|
FBXL5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.66639999974205E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.00509999995313E-07 |
| Normal-vs-Stage2 |
1.029830E-01 |
| Normal-vs-Stage3 |
8.438000E-03 |
| Normal-vs-Stage4 |
1.50598999999474E-05 |
| Stage1-vs-Stage2 |
4.249000E-01 |
| Stage1-vs-Stage3 |
9.288200E-01 |
| Stage1-vs-Stage4 |
3.001700E-02 |
| Stage2-vs-Stage3 |
4.987400E-01 |
| Stage2-vs-Stage4 |
2.764000E-02 |
| Stage3-vs-Stage4 |
1.058000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.0887000047648E-08 |
| Normal-vs-AfricanAmerican |
2.22399999999512E-05 |
| Normal-vs-Asian |
8.898600E-01 |
| Caucasian-vs-AfricanAmerican |
9.400400E-01 |
| Caucasian-vs-Asian |
6.074400E-01 |
| AfricanAmerican-vs-Asian |
6.131800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.12849999970244E-07 |
| Normal-vs-Female |
3.58510000000312E-05 |
| Male-vs-Female |
9.348800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.402540E-04 |
| Normal-vs-Extreme_Weight |
1.55619999997469E-06 |
| Normal-vs-Obese |
8.01210000012098E-07 |
| Normal-vs-Extreme_Obese |
3.299800E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.406800E-01 |
| Normal_Weight-vs-Obese |
9.441600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.417800E-01 |
| Extreme_Weight-vs-Obese |
8.544400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.453600E-01 |
| Obese-vs-Extreme_Obese |
3.280000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.02659999945409E-07 |
| Normal-vs-Age(41-60Yrs) |
1.400030E-04 |
| Normal-vs-Age(61-80Yrs) |
5.78049999977459E-07 |
| Normal-vs-Age(81-100Yrs) |
8.00149999999888E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.600300E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.049800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.514000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.760800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.914200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.980800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.71709999996494E-06 |
| Normal-VS-Type2 PRCC |
2.837700E-02 |
| Normal-VS-KIRP CIMP |
1.51989532071184E-13 |
| Normal-VS-Unclassified PRCC |
1.38309999997421E-06 |
| Type1 PRCC-VS-Type2 PRCC |
5.987900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
<1E-12 |
| Type1 PRCC-VS-Unclassified PRCC |
4.996800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.9840997168028E-10 |
| Type2 PRCC-VS-Unclassified PRCC |
3.891700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.93279877950204E-11 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.617200E-03 |
| Normal-vs-N1 |
1.43730000001785E-06 |
| Normal-vs-N2 |
2.35678143667428E-12 |
| N0-vs-N1 |
7.911600E-02 |
| N0-vs-N2 |
2.00489999999665E-05 |
| N1-vs-N2 |
4.084400E-03 |
|
|
